That same 0.1mL draw from a 2.5mg/mL vial contains only 0.25mg
GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
Tirzepatide may produce more severe side effects than semaglutide
In clinical practice, after several years of prescribing these medications, I can confidently say that patients experience a clear reduction in drinking frequency and a significant decrease in the rewarding or consummatory pleasure of alcohol, which leads them to consume considerably fewer drinks per drinking episode
Instead, you should rotate injection sites
.jpg)
